Ole-Bjørn Tysnes
Klinisk institutt 1
E-postOle-Bjorn.Tysnes@uib.no
Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
Vis forfatter(e) (2022). Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway. Neurology research international. 1-6.
Vis forfatter(e) (2022). Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA. Epigenetics. 16 sider.
Vis forfatter(e) (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 396-407.e6.
Vis forfatter(e) (2022). Severe Hyperhomocysteinemia in a Patient with Parkinson Disease. Clinical Chemistry. 396-401.
Vis forfatter(e) (2022). Parkinson's disease clinical milestones and mortality. NPJ Parkinson's Disease.
Vis forfatter(e) (2022). Mitochondrial haplogroups and cognitive progression in Parkinson's disease. Brain. 42-49.
Vis forfatter(e) (2022). Genetic Epidemiology of Amyotrophic lateral Sclerosis in Norway: A 2-Year Population-Based Study. Neuroepidemiology. 271-282.
Vis forfatter(e) (2022). GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study. Movement Disorders. 1016-1027.
Vis forfatter(e) (2022). Frailty in Parkinson's disease and its association with early dementia: A longitudinal study. Parkinsonism & Related Disorders. 51-57.
Vis forfatter(e) (2022). Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson's Disease. Biomolecules. 1-12.
Vis forfatter(e) (2022). Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease. Neurology. e388-e395.
Vis forfatter(e) (2021). Translation, cultural adaptation, and validation of a screening test for cognitive and behavioural changes in amyotrophic lateral sclerosis. Disability and Rehabilitation.
Vis forfatter(e) (2021). The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study. Neuroscience Letters. 1-7.
Vis forfatter(e) (2021). NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study. PLOS ONE. 1-11.
Vis forfatter(e) (2021). Lack of Association between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts. Journal of Parkinson's Disease. 1569-1578.
Vis forfatter(e) (2021). Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nature Genetics. 787-793.
Vis forfatter(e) (2021). Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain. Molecular Neurodegeneration. 1-20.
Vis forfatter(e) (2021). Early constipation predicts faster dementia onset in Parkinson's disease. NPJ Parkinson's Disease. 1-7.
Vis forfatter(e) (2021). Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients. Frontiers in Neurology. 1-7.
Vis forfatter(e) (2021). Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease. Neurology. e1036-e1044.
Vis forfatter(e) (2020). Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease. Parkinsonism & Related Disorders. 49-53.
Vis forfatter(e) (2020). Progression of fatigue in Parkinson's disease – a 9-year follow-up. European Journal of Neurology. 108-116.
Vis forfatter(e) (2020). Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci. PLOS ONE. 1-9.
Vis forfatter(e) (2020). Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden. Parkinsonism & Related Disorders. 27-30.
Vis forfatter(e) (2020). Genetic risk scores and hallucinations in patients with Parkinson disease. Neurology: Genetics. 9 sider.
Vis forfatter(e) (2020). Differential transcript usage in the Parkinson's disease brain. PLoS Genetics. 1-24.
Vis forfatter(e) (2020). Differences in the presentation and progression of Parkinson's disease by sex. Movement Disorders. 1-14.
Vis forfatter(e) (2020). Common gene expression signatures in Parkinson's disease are driven by changes in cell composition. Acta neuropathologica communications. 1-14.
Vis forfatter(e) (2019). The value of cerebrospinal fluid alpha-synuclein and the tau/alpha-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology. European Journal of Neurology. 43-50.
Vis forfatter(e) (2019). Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study. Neurology. e1526-e1534.
Vis forfatter(e) (2019). Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. Movement Disorders. 1839-1850.
Vis forfatter(e) (2019). Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts. Neurology: Genetics. 1-14.
Vis forfatter(e) (2019). Evolution of impulsive–compulsive behaviors and cognition in Parkinson's disease. Journal of Neurology. 259-266.
Vis forfatter(e) (2019). Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: Protocol for validation and a prospective cohort study. Contemporary Clinical Trials Communications. 1-7.
Vis forfatter(e) (2019). Combinatory microRNA serum signatures as classifiers of Parkinson's disease. Parkinsonism & Related Disorders. 202-210.
Vis forfatter(e) (2018). Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease. Neurobiology of Aging. 120-127.
Vis forfatter(e) (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. Movement Disorders. 1591-1600.
Vis forfatter(e) (2018). Laryngeal responses to mechanically assisted cough in progressing amyotrophic lateral sclerosis. Respiratory care. 538-549.
Vis forfatter(e) (2018). Inflammation and fatigue in early, untreated Parkinson's Disease. Acta Neurologica Scandinavica. 394-399.
Vis forfatter(e) (2018). Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. Acta Neurologica Scandinavica. 508-514.
Vis forfatter(e) (2018). Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease. Parkinsonism & Related Disorders. 4-8.
Vis forfatter(e) (2018). Dopaminergic and opioid pathways associated with impulse control disorders in Parkinson's disease. Frontiers in Neurology. 1-9.
Vis forfatter(e) (2018). Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease. Alzheimer's & Dementia. 1293-1301.
Vis forfatter(e) (2018). Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 303-310.
Vis forfatter(e) (2018). Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease. Neuroscience Letters. 123-126.
Vis forfatter(e) (2018). A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease. Movement Disorders. 298-299.
Vis forfatter(e) (2017). The natural history of depressive symptoms in patients with incident Parkinson?s disease: a prospective cohort study. Journal of Neurology. 1-8.
Vis forfatter(e) (2017). The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal. Neuroscience Letters. 48-52.
Vis forfatter(e) (2017). Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathologica. 409-425.
Vis forfatter(e) (2017). Natural course of mild cognitive impairment in Parkinson disease. Neurology. 767-774.
Vis forfatter(e) (2017). July 2017 ENCALS statement on edaravone. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 471-474.
Vis forfatter(e) (2017). Is fatigue associated with cognitive dysfunction in early Parkinson's disease? Parkinsonism & Related Disorders. 87-91.
Vis forfatter(e) (2017). Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study. Journal of Parkinson's Disease. 183-191.
Vis forfatter(e) (2017). Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. Movement Disorders. 241-245.
Vis forfatter(e) (2017). Epidemiology of Parkinson's disease. Journal of Neural Transmission.
Vis forfatter(e) (2017). Development and validation of prognostic survival models in newly diagnosed Parkinson's disease. Movement Disorders. 108-116.
Vis forfatter(e) (2017). Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study. Parkinsonism & Related Disorders. 28-33.
Vis forfatter(e) (2017). Bruk av avansert behandling ved Parkinsons sykdom i Norge. Tidsskrift for Den norske legeforening. 619-623.
Vis forfatter(e) (2016). Validation of a new assay for α-synuclein detection in cerebrospinal fluid. Clinical Chemistry and Laboratory Medicine. 254-260.
Vis forfatter(e) (2016). Utredning ved mistenkt kronisk utmattelsessyndrom/ myalgisk encefalopati. Tidsskrift for Den norske legeforening. 227-232.
Vis forfatter(e) (2016). Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 256-264.
Vis forfatter(e) (2016). Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Parkinsonism & Related Disorders. 48-53.
Vis forfatter(e) (2016). Reliability of three disability scales for detection of independence loss in Parkinson's Disease. Parkinson's Disease. 1-6.
Vis forfatter(e) (2016). Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age–period–cohort study. Journal of Neurology. 1-8.
Vis forfatter(e) (2016). Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study. Neurology. 1599-1606.
Vis forfatter(e) (2016). Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study. Journal of Neurology. 364-372.
Vis forfatter(e) (2016). Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis. Thorax. 221-229.
Vis forfatter(e) (2016). Impact of Falls on Physical Activity in People with Parkinson's Disease. Journal of Parkinson's Disease. 175-182.
Vis forfatter(e) (2016). Fatigue in early Parkinson's disease: the Norwegian ParkWest study. European Journal of Neurology. 105-111.
Vis forfatter(e) (2016). Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nature Communications. 11 sider.
Vis forfatter(e) (2016). Changes in insomnia subtypes in early Parkinson disease. Neurology. 352-358.
Vis forfatter(e) (2015). The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Alzheimer's & Dementia. 1407-1416.
Vis forfatter(e) (2015). HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia. Proceedings of the National Academy of Sciences of the United States of America.
Vis forfatter(e) (2015). Fine mapping and resequencing of the PARK16 locus in Parkinson's disease. Journal of Human Genetics. 357-362.
Vis forfatter(e) (2015). Development of excessive daytime sleepiness in early Parkinson disease. Neurology. 162-168.
Vis forfatter(e) (2015). Association of a BACE1 gene polymorphism with Parkinson's disease in a Norwegian population. Parkinson's Disease. 5 sider.
Vis forfatter(e) (2014). The factor structure of the UPDRS motor scores changes during early Parkinson's disease. Parkinsonism & Related Disorders. 617-621.
Vis forfatter(e) (2014). Terapianbefaling Parkinsons sykdom. Nyhetsbulletin. 5-29.
Vis forfatter(e) (2014). Medisinering av Parkinsonpasienter som trenger kirurgisk behandling I generell anestesi. Nyhetsbulletin. 10-11.
Vis forfatter(e) (2014). CSF Aβ42 predicts early-onset dementia in Parkinson disease. Neurology. 1784-1790.
Vis forfatter(e) (2013). Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry. 23-28.
Vis forfatter(e) (2013). Treatment in early Parkinson's disease: the Norwegian ParkWest study. Acta Neurologica Scandinavica. 107-113.
Vis forfatter(e) (2013). Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiology of Aging. 7 sider.
Vis forfatter(e) (2013). Prognosis of Mild Cognitive Impairment in Early Parkinson Disease. JAMA Neurology. 580-586.
Vis forfatter(e) (2013). Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study. Parkinsonism & Related Disorders. 53-55.
Vis forfatter(e) (2013). Laryngeal response patterns to mechanical insufflation-exsufflation in healthy subjects. American Journal of Physical Medicine & Rehabilitation. 920-929.
Vis forfatter(e) (2013). Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism & Related Disorders. 1027-1032.
Vis forfatter(e) (2013). Cerebrospinal fluid amyloid-beta and phenotypic heterogeneity in de novo Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry. 537-543.
Vis forfatter(e) (2013). Cerebrospinal fluid A levels correlate with structural brain changes in Parkinson's disease. Movement Disorders. 302-310.
Vis forfatter(e) (2013). Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease. Acta Neurologica Scandinavica. 290-294.
Vis forfatter(e) (2012). White Matter Hyperintensities in Mild Lewy Body Dementia. Dementia and Geriatric Cognitive Disorders Extra. 481-495.
Vis forfatter(e) (2012). Subjective sleep problems in patients with early Parkinson's disease. European Journal of Neurology. 1575-1581.
Vis forfatter(e) (2012). Psychometric Properties of the Starkstein Apathy Scale in Patients With Early Untreated Parkinson Disease. The American journal of geriatric psychiatry. 142-148.
Vis forfatter(e) (2012). Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion (Amsterdam. Print). 640-643.
Vis forfatter(e) (2012). Novel TARDBP mutations in Nordic ALS patients. Journal of Human Genetics. 316-319.
Vis forfatter(e) (2012). Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines. Journal of the Neurological Sciences. 211-216.
Vis forfatter(e) (2012). Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment. Neurobiology of Aging. 2113-2124.
Vis forfatter(e) (2012). Fatigue in early Parkinson's disease. Minor inconvenience or major distress? European Journal of Neurology. 963-968.
Vis forfatter(e) (2012). Comparing Hippocampal Atrophy in Alzheimer's Dementia and Dementia with Lewy Bodies. Dementia and Geriatric Cognitive Disorders. 44-50.
Vis forfatter(e) (2011). Verbal memory in drug-naive, newly diagnosed Parkinson's Disease. The retrieval deficit hypothesis revisited. Neuropsychology. 114-124.
Vis forfatter(e) (2011). Ventricular enlargement and mild cognitive impairment in early Parkinson's Disease. Movement Disorders. 297-301.
Vis forfatter(e) (2011). Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology. 1941-1946.
Vis forfatter(e) (2011). Autonomic and sensory symptoms and signs in incident, untreated Parkinson's Disease : frequent but mild. Movement Disorders. 65-72.
Vis forfatter(e) (2011). Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Human Molecular Genetics. 1697-1700.
Vis forfatter(e) (2010). The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study. Acta Neurologica Scandinavica. 438-441.
Vis forfatter(e) (2010). Gray matter correlations of cognition in incident Parkinson's disease. Movement Disorders. 629-633.
Vis forfatter(e) (2010). Differential Effect of Environmental Risk Factors on Postural Instability Gait Difficulties and Tremor Dominant Parkinson's Disease. Movement Disorders. 1847-1852.
Vis forfatter(e) (2010). Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson's disease: the Norwegian ParkWest study. Acta Neurologica Scandinavica. 418-424.
Vis forfatter(e) (2010). CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery and Psychiatry. 1080-1086.
Vis forfatter(e) (2010). Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study. Journal of Neurology. 217-223.
Vis forfatter(e) (2009). White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. NeuroImage. 2083-2089.
Vis forfatter(e) (2009). The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry. 928-930.
Vis forfatter(e) (2009). Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery and Psychiatry. 851-857.
Vis forfatter(e) (2009). High Prevalence of Orthostatic Hypotension in Mild Dementia. Dementia and Geriatric Cognitive Disorders. 307-313.
Vis forfatter(e) (2009). Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study. Neurology. 1121-1126.
Vis forfatter(e) (2009). Brain Atrophy and White Matter Hyperintensities in Early Parkinson's Disease. Movement Disorders. 2233-2241.
Vis forfatter(e) (2008). Treatment of sialorrhea in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 77-81.
Vis forfatter(e) (2007). Demens ved Parkinsons sykdom. Tidsskrift for Den norske legeforening. 2517-2520.
Vis forfatter(e) (2006). Bergen International symposium in neuroimmunology 2006. Introduction. Acta Neurologica Scandinavica, Supplementum. v-vi.
Vis forfatter(e) (2004). Neuroborreliosis with stroke-like manifestations. European Neurology. 49-50.
Vis forfatter(e) (2004). Epidemiology and management of ALS. Advances in Clinical Neuroscience & Rehabilitation. 8-9.
Vis forfatter(e) (2003). Risk of variant Creutzfeldt-Jakob disease and toncillectomy. Archives of Oto-Rhino-Laryngology. 141-144.
Vis forfatter(e) (2003). GM1-antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 141-144.
Vis forfatter(e) (2002). Kraniocervical arteriedisseksjon. Tidsskrift for Den norske legeforening. 2355-2357.
Vis forfatter(e) (2002). Etiologi og genetikk ved Alzheimers sykdom. Tidsskrift for Den norske legeforening. 50-53.
Vis forfatter(e) (2002). Cystic Dilatation of Virchow-Robin Spaces in the Midbrain. European Neurology. 186-188.
Vis forfatter(e) (2001). Hemiballisme ved hjerneinfarkt. Tidsskrift for Den norske legeforening. 2593-2595.
Vis forfatter(e) (2001). Epidemiology of ALS. Increasing incidence? Profile. 6-7.
Vis forfatter(e) (2000). Polynevropati er et tidlig funn ved primært systemisk amyloidose. Tidsskrift for Den norske legeforening. 1291-1293.
Vis forfatter(e) (2000). Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 1262-1266.
Vis forfatter(e) (2000). Diffusjonsvektet magnetisk resonanstomografi - nytt i diagnostikken av Creutzfeldt-Jakob sykdom. Tidsskrift for Den norske legeforening. 675-677.
Vis forfatter(e) (1999). Dolikoektasi av intrakraniale arterier og hjerneslag. Tidsskrift for Den norske legeforening. 3004-3005.
Vis forfatter(e) (1999). Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro. Anticancer Research. 149-56.
Vis forfatter(e) (1998). Expression of annexin II in glioma cell lines and in brain tumor biopsies. Journal of Neuro-Oncology. 11-18.
Vis forfatter(e) (1998). Dynamic determination of human glioma invasion in vitro. Journal of Neurosurgery. 441-447.
Vis forfatter(e) (1997). Skrapesyke, kugalskap og Creutzfeldt-Jakobs sjukdom. Naturen. 81-90.
Vis forfatter(e) (1997). Fem års erfaringer med en amyotrofisk lateralsklerose klinikk. Tidsskrift for Den norske legeforening. 1892-1895.
Vis forfatter(e) (1997). En ny variant av Creutzfeldt-Jakobs sjukdom. Vil vi sjå utvikling av ein epidemi? Tidsskrift for Den norske legeforening. 384-388.
Vis forfatter(e) (1997). Adhesion and migration of glioma cells are differently dependent on extracellular matrix molecules. Anticancer Research. 1035-1043.
Vis forfatter(e) (1994). Varicella zoster-infeksjoner og neurologiske komplikasjoner. Tidsskrift for Den norske legeforening. 2484-2486.
Vis forfatter(e) (1994). Varicella zoster-infeksjoner of neurologiske komplikasjoner. Tidsskrift for Den norske legeforening. 2484-2486.
Vis forfatter(e) (1994). Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 226-235.
Vis forfatter(e) (1994). Organic solvents activate human platelets through the inositol lipid-linked signal transduction system. Platelets. 266-271.
Vis forfatter(e) (1994). Organic solvents activate human platelets through the inositol lipid-linked signal tranduction system. Platelets. 266-271.
Vis forfatter(e) (1994). Hydrophobic organic solvents activate human platelets through inositol lipid metabolism. Platelets. 266-271.
Vis forfatter(e) (1994). Hydrophobic organic solvents activate human platelets in vitro. Platelets. 193-200.
Vis forfatter(e) (1994). Development of methionine dependence in a human glioma cell line. Relation to homocysteine remethylation and cobalamin status. Cancer Research. 4899-4906.
Vis forfatter(e) (1994). Development of methionine dependence in a human glioma cell line. Relation to homocystein remethylation and cobalamin status. Cancer Research. 4899-4906.
Vis forfatter(e) (1994). Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis. Autoimmunity. 327-331.
Vis forfatter(e) (1994). Activation of blood platelets in workers exposed to organic solvents. Platelets. 193-200.
Vis forfatter(e) (1993). The significance of radiologically diagnosed brain concussion for the outcome after head injury. Tidsskrift for Den norske legeforening. 1227-1229.
Vis forfatter(e) (1993). IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. Journal of Autoimmunity. 507-515.
Vis forfatter(e) (1993). Differential effects of 12-O-tetradecanoyl-13-phorbol acetate (TPA) on growth, migration and invasion of a human glioma cell line. Anticancer Research. 1325-1330.
Vis forfatter(e) (1993). Betydningen av radiologisk påvist hjernekontusjon for resultatet av hodeskade. Tidsskrift for Den norske legeforening. 1227-1229.
Vis forfatter(e) (1992). Ryanodine Receptor Autoantibodies in Myasthenia Gravis Patients with a Thymoma. Annals of Neurology. 589-591.
Vis forfatter(e) (1992). Perifer facialisparese som symptom på infeksjon med Borrelia burgdorferi. Tidsskrift for Den norske legeforening. 50-51.
Vis forfatter(e) (1992). Inositol phospholipid metabolism in resting and stimulated human platelets. Cellular Signalling. 611-617.
Vis forfatter(e) (1992). Early and late outcome in head-injured patients with radiological evidence of brain damage. Comparison with patients substaining brain concussion. Acta Neurologica Scandinavica. 194-198.
Vis forfatter(e) (1992). Early and late outcome in head injury patients with radiological evidence of brain damage. Acta Neurologica Scandinavica. 194-198.
Vis forfatter(e) (1992). Activation of blood platelets in workers exposed to organic solvents. J Occ Med. 687-692.
Vis forfatter(e) (1991). Stimulation of human platelets with low concentrations of thrombin: Evidence for equimolecular formation of inositol triphosphate and phosphatidic acid. International journal of biochemistry. 305-310.
Vis forfatter(e) (1991). Epidemiology of amytrophic lateral sclerosis in Hordaland County, western Norway. Acta Neurologica Scandinavica. 280-285.
Vis forfatter(e) (1991). Epidemiology of amyotrophic lateral sclerosis in Hordaland county, Western Norway. Acta Neurologica Scandinavica. 280-285.
Vis forfatter(e) (1991). Amyotrofisk lateral sklerose; forekomst og prognose. Tidsskrift for Den norske legeforening. 2634-2636.
Vis forfatter(e) (2013). I hvilken grad vurderer Nevrologer førerkortforskriften likt.
Vis forfatter(e) (2013). Førerkortforskriften:Hva betyr de nye reglene for deg som nevrolog?
Vis forfatter(e) (2002). Do Riluzole or PEG affect survival in ALS.
Vis forfatter(e) (2000). Utredning og behandling av amyotrofisk lateralsklerose. ALS kompendium. 5-9.
Vis forfatter(e) (2000). Creutzfeldt-Jakobs sykdom i Norge. Demens i allmennpraksis. 1-2.
Vis forfatter(e) (2019). Hvor står ALS-forskningen i Norge? VG : Verdens gang.
Vis forfatter(e) (2014). Motornevronsykdommer. 5 sider.
Vis forfatter(e) (1992). Polyphosphoinositide metabolism in resting and stimulated platelets. 20 sider.
Vis forfatter(e) (1991). Epidemiology of amyotrophic lateral sclerosis in Hordaland county, Western Norway. 7 sider.
Sammendrag/abstract
Vis forfatter(e) (2012). Impact of treatment on quality of life in early and drug-naive Parkinson's disease: the Norwegian ParkWest study. European Journal of Neurology. 58-58.
Vis forfatter(e) (2012). A Scandinavian multi-centre study replicates 11 susceptibility loci from genome-wide association studies in Parkinson's disease. European Journal of Neurology. 40-40.
Vis forfatter(e) (2020). Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing. Mechanisms of Ageing and Development. 1-6.
Vis forfatter(e) (2014). Genetisk sammenheng mellom amyotrofisk lateral sklerose og frontotemporal demens. Tidsskrift for Den norske legeforening. 302-306.
Vis forfatter(e) (2010). Ny kunnskap om Creutzfeldt-Jakobs sykdom kan gi terapeutiske muligheter. Tidsskrift for Den norske legeforening. 601-604.
Vis forfatter(e) (2010). Are dysautonomic and sensory symptoms present in early Parkinson's disease? Acta Neurologica Scandinavica. 72-77.
Vis forfatter(e) (2009). Neurological examination of cortical function deficits. Acta Neurologica Scandinavica. 58-62.
Vis forfatter(e) (2004). Parkinsons sykdom: Nevroproteksjon ved COX 2 hemming? Nyhetsbulletin, Interessegruppen for Parkinsons sykdom i Norge. 7-8.
Vis forfatter(e) (2004). Nevroproteksjon av Coenzym Q10 ved Parkinsons sykdom. Nyhetsbulletin, Interessegruppen for Parkinsons sykdom i Norge. 9-10.
Vis forfatter(e) (2004). Fremtidsutsikter for PD-rammede. Parkinsonposten. 36-37.